These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 22554901)

  • 1. Evaluation of novel assays to assess the influence of different iron sources on the growth of Clostridium difficile.
    Cernat RC; Scott KP
    Anaerobe; 2012 Jun; 18(3):298-304. PubMed ID: 22554901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential of lactoferrin to prevent antibiotic-induced Clostridium difficile infection.
    Chilton CH; Crowther GS; Śpiewak K; Brindell M; Singh G; Wilcox MH; Monaghan TM
    J Antimicrob Chemother; 2016 Apr; 71(4):975-85. PubMed ID: 26759363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of Staphylococcus aureus isolates from bovine mastitis to exogenous iron sources.
    Diarra MS; Petitclerc D; Lacasse P
    J Dairy Sci; 2002 Sep; 85(9):2141-8. PubMed ID: 12362445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tritrichomonas foetus: iron acquisition from lactoferrin and transferrin.
    Tachezy J; Kulda J; Bahníková I; Suchan P; Rázga J; Schrével J
    Exp Parasitol; 1996 Jul; 83(2):216-28. PubMed ID: 8682190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of iron regulation on expression and hemin-binding function of outer-sheath proteins from Treponema denticola.
    Chu L; Song M; Holt SC
    Microb Pathog; 1994 May; 16(5):321-35. PubMed ID: 7815916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth of Legionella spp. under conditions of iron restriction.
    Goldoni P; Visca P; Pastoris MC; Valenti P; Orsi N
    J Med Microbiol; 1991 Feb; 34(2):113-8. PubMed ID: 1824950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of iron limitation on the growth of Aeromonas salmonicida.
    Neelam B; Robinson RA; Price NC; Stevens L
    Microbios; 1993; 74(298):59-67. PubMed ID: 8336555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of different iron sources and their influence in biofilm formation by the dental pathogen Actinobacillus actinomycetemcomitans.
    Rhodes ER; Shoemaker CJ; Menke SM; Edelmann RE; Actis LA
    J Med Microbiol; 2007 Jan; 56(Pt 1):119-128. PubMed ID: 17172526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of host iron transport compounds on growth kinetics and outer-membrane protein expression of Bilophila wadsworthia.
    Daniel C; Bissinger MC; Courcol RJ
    Anaerobe; 1998 Apr; 4(2):103-9. PubMed ID: 16887629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rabbit reticulocyte model for the role of hemin-controlled repressor in hypochromic anemias.
    Freedman ML; Rosman J
    J Clin Invest; 1976 Mar; 57(3):594-603. PubMed ID: 2617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use and endocytosis of iron-containing proteins by Entamoeba histolytica trophozoites.
    López-Soto F; León-Sicairos N; Reyes-López M; Serrano-Luna J; Ordaz-Pichardo C; Piña-Vázquez C; Ortiz-Estrada G; de la Garza M
    Infect Genet Evol; 2009 Dec; 9(6):1038-50. PubMed ID: 19539057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproducibility of broth microdilution and comparison to agar dilution for testing CB-183,315 against clinical isolates of Clostridium difficile.
    Citron DM; Goldstein EJ
    Diagn Microbiol Infect Dis; 2011 Aug; 70(4):554-6. PubMed ID: 21767714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of four rapid methods for the investigation of the toxigenic capacity of Clostridium difficile strains isolated in a selective medium].
    García A; Pérez JL; Pulido A; Niubó J; Pérez P; Martín R
    Enferm Infecc Microbiol Clin; 2000 Mar; 18(3):109-12. PubMed ID: 10905010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fidaxomicin: a macrocyclic antibiotic for the management of Clostridium difficile infection.
    Sullivan KM; Spooner LM
    Ann Pharmacother; 2010 Feb; 44(2):352-9. PubMed ID: 20071495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of metal chelators and other metabolic inhibitors on the growth of Bifidobacterium bifidus var. Pennsylvanicus.
    Bezkorovainy A; Topouzian N
    Clin Biochem; 1981 Jun; 14(3):135-41. PubMed ID: 6794942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Susceptibility of Clostridium difficile to metronidazole using the E-test: effect of the culture medium].
    Poilane I; Cruaud P; Rousseau JG; Torlotin JC; Collignon A
    Pathol Biol (Paris); 1999 May; 47(5):515-8. PubMed ID: 10418031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contributions to the taxonomy and biology of Clostridium difficile.
    Bittner J; Macovei A; Lemeni D; Arboreanu D; Potorac E
    Roum Arch Microbiol Immunol; 1992; 51(4):253-62. PubMed ID: 1304829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved recovery of Clostridium difficile spores with the incorporation of synthetic taurocholate in cycloserine-cefoxitin-fructose agar (CCFA).
    Foster NF; Riley TV
    Pathology; 2012 Jun; 44(4):354-6. PubMed ID: 22531346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of dietary catechols on the growth of enteropathogenic bacteria.
    Freestone PP; Walton NJ; Haigh RD; Lyte M
    Int J Food Microbiol; 2007 Nov; 119(3):159-69. PubMed ID: 17850907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug resistance in European Clostridium difficile clinical isolates.
    Spigaglia P; Barbanti F; Mastrantonio P;
    J Antimicrob Chemother; 2011 Oct; 66(10):2227-34. PubMed ID: 21771851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.